We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
ClearBridge Investments
351
ClearBridge Investments
New York
$39K +$127 +1 +0.4%
GXMC
352
Global X Management Company
New York
$38K +$8.39K +66 +35%
PA
353
Parallel Advisors
California
$34K +$1.27K +10 +5%
CHP
354
Cable Hill Partners
Oregon
$33K +$15.6K +123 +123%
1832 Asset Management
355
1832 Asset Management
Ontario, Canada
$32K -$37.5K -295 -58%
FHA
356
First Horizon Advisors
Tennessee
$32K – – –
STA
357
Summit Trail Advisors
New York
$30K +$27.8K +219 New
FGC
358
Financial Gravity Companies
Texas
$30K +$29.1K +229 New
MA
359
MCF Advisors
Kentucky
$28K – – –
BBHC
360
Brown Brothers Harriman & Co
New York
$28K +$3.81K +30 +19%
RFC
361
Regions Financial Corp
Alabama
$27K +$22.9K +180 New
Northwestern Mutual Wealth Management
362
Northwestern Mutual Wealth Management
Wisconsin
$24K -$1.14K -9 -5%
LJHT
363
Laurie J. Hall Trustee
$22K – – –
PCP
364
Proficio Capital Partners
Massachusetts
$22K +$2.92K +23 +18%
DCM
365
Delpha Capital Management
New York
$20K +$17.5K +138 New
SPIA
366
Steward Partners Investment Advisory
New York
$19K – – –
GAM
367
Gemmer Asset Management
California
$17K – – –
BGIM
368
Brandywine Global Investment Management
Pennsylvania
$16K -$9.72M -76,461 -100%
PWM
369
Perigon Wealth Management
California
$16K – – –
AF
370
Arrow Financial
New York
$15K – – –
Carson Wealth (CWM LLC)
371
Carson Wealth (CWM LLC)
Nebraska
$15K – – –
CBOA
372
Commonwealth Bank of Australia
Australia
$14K – – –
Loomis, Sayles & Company
373
Loomis, Sayles & Company
Massachusetts
$13K -$6.61K -52 -38%
PI
374
PineBridge Investments
New York
$13K +$1.02K +8 +10%
WCBA
375
Weaver C. Barksdale & Associates
Tennessee
$10K -$381 -3 -4%
13 14
15
16 17

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.